The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 59 | — | 20.1x | Near average | |
Growth | 36 | -1.8% | 5.6% | Near average | |
Quality | 67 | -138.2% | 7.6% | Above average | |
Safety | 36 | -2.0x | 0.4x | Near average | |
Capital Return | 5 | — | 2.19% | Below average | |
Momentum | 78 | — | — | Above average | |
Sentiment | 23 | — | — | Below average |
P3 Health Partners Inc. is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy P3 Health Partners Inc. shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
The analyst outlook for PIII has undergone a significant shift over the past 30 days, with the average price target jumping by 125% from $4 to $9, driven by a new analyst entering the coverage range. Despite this increase in the average, there is significant dispersion in opinions, with targets ranging between $4 and $14, reflecting operational uncertainty despite the recent price optimism.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.